Activist 13D/13G Filings - KALA BIO Inc. (KALA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-11-14
4:49 pm
Purchase		13GKala Pharmaceuticals, Inc.
KALA		ADAR1 Capital Management LLC480,431
9.990%		480,431increase
(New Position)		View
2024-07-08
8:54 pm
Purchase		13DKala Pharmaceuticals, Inc.
KALA		SR ONE CAPITAL MANAGEMENT LLC445,643
9.990%		445,643increase
(New Position)		View
2024-06-28
4:11 pm
Purchase		13DKala Pharmaceuticals, Inc.
KALA		BAKER BROS. ADVISORS LP891,335
19.990%		622,122increase
(+231.09%)		View
2024-02-16
4:11 pm
Purchase		13GKala Pharmaceuticals, Inc.
KALA		MILLENNIUM MANAGEMENT LLC135,096
5.000%		135,096increase
(New Position)		View
2024-02-14
4:21 pm
Purchase		13GKala Pharmaceuticals, Inc.
KALA		BAKER BROS. ADVISORS LP269,213
9.990%		88,300increase
(+48.81%)		View
2024-02-14
1:09 pm
Sale		13GKala Pharmaceuticals, Inc.
KALA		Checkpoint Capital L.P.0
0.000%		-228,032decrease
(Position Closed)		View
2024-01-29
4:36 pm
Sale		13GKala Pharmaceuticals, Inc.
KALA		Integrated Core Strategies (US) LLC132,674
4.900%		-1,029decrease
(-0.77%)		View
2023-10-18
4:04 pm
Unchanged		13DKala Pharmaceuticals, Inc.
KALA		Longitude Capital Partners II LLC108,239
4.300%		0
(Unchanged)		View
2023-06-15
11:57 am
Purchase		13GKala Pharmaceuticals, Inc.
KALA		Checkpoint Capital L.P.228,032
9.700%		228,032increase
(New Position)		View
2023-02-14
4:15 pm
Sale		13DKala Pharmaceuticals, Inc.
KALA		Longitude Capital Partners II LLC108,239
6.300%		-5,348,791decrease
(-98.02%)		View
2023-02-14
4:00 pm
Purchase		13GKala Pharmaceuticals, Inc.
KALA		BAKER BROS. ADVISORS LP180,913
9.990%		180,913increase
(New Position)		View
2023-01-17
4:38 pm
Purchase		13GKala Pharmaceuticals, Inc.
KALA		Integrated Core Strategies (US) LLC133,703
8.400%		133,703increase
(New Position)		View
2022-06-03
5:11 pm
Sale		13DKala Pharmaceuticals, Inc.
KALA		RA CAPITAL MANAGEMENT L.P.3,412,868
4.700%		-2,781,921decrease
(-44.91%)		View
2022-05-31
5:31 pm
Sale		13DKala Pharmaceuticals, Inc.
KALA		RA CAPITAL MANAGEMENT L.P.6,194,789
8.530%		-1,850,510decrease
(-23.00%)		View
2022-05-25
5:12 pm
Sale		13DKala Pharmaceuticals, Inc.
KALA		RA CAPITAL MANAGEMENT L.P.8,045,299
11.080%		-2,869,314decrease
(-26.29%)		View
2022-04-01
4:30 pm
Sale		13DKala Pharmaceuticals, Inc.
KALA		RA CAPITAL MANAGEMENT L.P.10,914,613
15.030%		-46,920decrease
(-0.43%)		View
2022-02-14
11:50 am
Sale		13GKala Pharmaceuticals, Inc.
KALA		EVENTIDE ASSET MANAGEMENT LLC0
0.000%		-3,450,000decrease
(Position Closed)		View
2022-01-10
12:54 pm
Sale		13GKala Pharmaceuticals, Inc.
KALA		BlackRock Inc.
BLK		3,134,773
4.800%		-25,733decrease
(-0.81%)		View
2021-11-26
4:17 pm
Purchase		13DKala Pharmaceuticals, Inc.
KALA		Lagunita LLC5,341,120
7.300%		5,341,120increase
(New Position)		View
2021-11-26
4:16 pm
Purchase		13DKala Pharmaceuticals, Inc.
KALA		Lagunita Biosciences LLC5,341,120
7.300%		5,341,120increase
(New Position)		View
Goto 0, 1, Next